Clinical Trial Update: Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO) [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial (TECHNO) evaluating a paclitaxel, epirubicin, cyclophosphamide, and trastuzumab regimen for breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin (epirubicin)
• HERCEPTIN (trastuzumab)
• Taxol (paclitaxel)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED